Allergy therapy for patients with a cardiac channelopathy: Do not withhold lifesaving treatments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Allergy therapy for patients with a cardiac channelopathy: Do not withhold lifesaving treatments

Published:2024-07 Issue: Volume: Page:
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Tseng Andrew S.,Giudicessi John R.,Ackerman Michael J.^ORCID

Funder

Mayo Clinic

Publisher

Elsevier BV

Reference5 articles.

1. Anaphylaxis: a 2023 practice parameter update;Golden;Ann Allergy Asthma Immunol,2024

2. Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics;Postema;Europace,2013

3. Risk of anaphylaxis in patients receiving beta-blocker drugs;Toogood;J Allergy Clin Immunol,1988

4. Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections;Hepner;J Allergy Clin Immunol,1990

5. Relationship between anaphylaxis and use of beta-blockers and angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis of observational studies;Tejedor-Alonso;J Allergy Clin Immunol Pract,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP